讨论了《中国药典》中存在的有效数字问题。
The problems of effective digits in the Chinese Pharmacopoeia are discussed.
并将此法与中国药典法进行差别检验，无显著差异。
There is no evident difference compared with Chinese Pharmacopoeia method.
方法通过查阅中国药典和日本药局方，比较生药来源。
Methods By consulting Pharmacopoeia of China and Japanese Pharmacopoeia, the source of the crude drugs was compared.
方法依照《中国药典》2000年版的方法和指导原则。
Methods Test was carried out according to the guideline and procedure specified in Chinese Pharmacopeia. 2000.
稳定性考察结果符合《中国药典》2000年版的规定。
The stability investigation results were in line with the requirement of Chinese Pharmacopeia 2000 version.
结果本方法满足中国药典2005版验证试验的基本要求。
Result the method can compatible with the validation test of Chinese Pharmacopoeia 2005 version.
方法按中国药典2000 年版二部方法和指导原则进行实验。
METHODS Test was carried out according to the guideline and procedure specified in China Pharmacopoeia 2000.
方法参照中国药典2000年版细菌内毒素检查法及热原检查法。
Methods The methods of bacterial endotoxins test and pyrogen test in Chinese pharmacopeia 2000 were used.
方法按《中国药典》2005年版附录无菌检查法项下薄膜过滤法。
Methods the method was based on the membrane filtration of sterility test of Chinese Pharmacopoeia 2005.
中国药典中骨碎补项下收载的品种为水龙骨科植物槲蕨的干燥根茎。
The species recorded on the "Rhizoma Drynariae" item of Chinese Pharmacopeia is the dry rhizoma of Drynaria fortunei from Polypodiacae.
按《中国药典》(2005年版)微生物限度检查法进行验证和试验。
To testify and check with the microbial limit test of 2005 "Chinese Pharmacopoeia".
依据《中国药典》2000年版建立质量标准并对3批产品进行检查。
Quality standard was established according to ChP2000 and 3 batches of product were tested.
方法：参照中国药典2000年版二部细菌内毒素检查法要求进行试验。
Method: Experiment was conducted according to bacteria endotoxin test in China Phannacopeia 2000, second section.
方法：参照中国药典2000年版二部细菌内毒素检查法要求进行试验。
Method: a experiment was conducted according to the testing method of bacteria endotoxin in China Pharmacopeia 2000, second section.
结果：二年实际有效期内各项指标符合中国药典2005版质量标准要求。
Results: Each index is accorded with the quality level re - quest in Chinese Pharmacopoeia 2005 in the 2 years validity time.
结论：用该工艺制备的大蒜乳剂符合《中国药典》2005年版乳剂要求。
Conclusion: the garlic emulsion prepared by this composition and technology accords with the stipulation of Chinese Pharmacopoeia (2005).
同时也推断论证了《中国药典》中有关红景天药材来源的说明中出现的问题。
In addition, the author questioned and discussed possible problems existed in the relative instruction of《Chinese Pharmacopoeia》.
方法采用《中国药典》2005年版二部动态浊度法定量检测细菌内毒素含量。
Methods the turbidimetric kinetic assay was adopted to quantitatively analyze the content of bacterial endotoxin, according to China Pharmacopoeia (2005 Edition 2).
目的：探讨制备布洛芬片新的工艺条件，以达到中国药典1995年版新标准。
OBJECTIVE: to study the preparation techniques of ibuprofen tablet to meet the standard of Chinese pharmacopoeia 1995.
结果：在薄层色谱中可检出大黄的特征斑点，药材标准符合《中国药典》规定。
Results:Rhubarb could be tested by using TLC, and the quality criteria of crude drug was fit for China Pharmacopeia.
方法：采用《中国药典2000年版》二部附录中检测细菌内毒素的动态浊度法。
Methods: the test was performed by the Turbidimetric-kinetic method that had been given by the Chinese Pharmacopoeia (Edition 2000).
目的替换《中国药典》(2005年版一部)薄层鉴别中使用苯和甲苯的展开剂。
Objective to replace the developing agents benzene and toluene in thin-layer chromatography in the Chinese Pharmacopoeia 2005 Volume I.
结果：参照《中国药典》结果判断，该组输液稀释5倍后能排除干扰，进行检测。
Results:The results to determine by reference China Pharmacopceia, the group infusion which diluted 5-fold had no interference on the test.
结果：薄膜过滤法的菌落回收率符合2005年版《中国药典(二部)》相关规定。
Results the colony recovery of membrane filtration method meets the related regulations of Chinese Pharmacopoeia (2005 edition).
方法采用2005年版《中国药典》细菌内毒素的动态浊度法测定血塞通注射液内毒素。
METHODS: The kinetic turbidimetry assay, stipulated in China Pharmacopeia (2005 Edition), was adopted for determination of bacterial endotoxin in Xuesaitong injection.
方法：采用精制处理后的检查专用试验水，按《中国药典》方法检查纯化水中的重金属。
METHODS:Heavy metals in the purified water were detected by the refined testing water specifically for detection in accordance with Chinese Pharmacopoeia .
方法：确定处方组成和制备工艺，按《中国药典》规定进行质量控制，并进行临床应用。
Method: Determining the composition of prescription and preparative technology, controlling the mass according to the regulations set by Chinese pharmacopoeia and practicing clinically.
方法采用中国药典2005年版一部规定的常规法、培养基稀释法进行菌回收率比较试验。
Methods Common methods in Chinese Pharmacopoeia(edition 2005) were used to cultivate culture media dilution, using recovery rate of the bacteria in the comparison experiment.
结论：建议再版的中国药典对供静脉注射的小容量注射液应规定进行不溶性微粒限度检查。
Conclusions: a suqqestion is the limit of insoluble corpuscle in small dlse of intravenous injection should be provided in the republished chinese phamacopeia.
结论：建议再版的中国药典对供静脉注射的小容量注射液应规定进行不溶性微粒限度检查。
Conclusions: a suqqestion is the limit of insoluble corpuscle in small dlse of intravenous injection should be provided in the republished chinese phamacopeia.
应用推荐